Josef H von Rickenbach bought $50K of RNTX stock

Josef H von Rickenbach, Dir of Rein Therapeutics, Inc. (RNTX), bought 47,060 shares of RNTX stock worth $50K, per an SEC Form 4 filed May 28, 2026.

It was an open-market purchase.

The trade happened on May 21, 2026, 7 days before it was made public.

RNTX has moved -46.9% since the trade date, from $1.04 to $0.55 (Nov 13, 2026 close).